期刊文献+

基于微流控平台的胶质母细胞瘤干细胞中miRNA-874表达的研究

Study of the expression of miRNA-874 in glioblastoma stem cells based on microfluidic platform
原文传递
导出
摘要 目的通过微流控检测平台,研究miRNA-874(miR-874)表达在胶质母细胞瘤干细胞(GSCs)生长中的作用及意义。方法应用高通量、多样本、低成本的微流控技术,对GSCs和神经干细胞(NSCs)进行miR-874转染,并通过荧光定量PCR检测细胞内miR-874和mRNA表达等一系列细胞分子生物实验,研究miRNA-874对GSCs生长和凋亡的作用。结果miR-874在GSCs中的表达显著降低,约为NSCs中表达量的2%~40%(P<0.05)。利用树状分子将miR-874转染入GSCs中后,GSCs的细胞数量显著下降,凋亡细胞的数量显著上升,提示miR-874对GSCs具有杀伤作用。结论miR-874在GSCs中表达显著降低,在GSCs中过表达miR-874会导致显著的细胞生长抑制和死亡,有助于开发基于miRNA的新型脑癌药物和疗法。 Objective To investigate the role and significance of the expression of miRNA-874(miR-874)in the growth of glioblastoma stem cells(GSCs)by microfluidic detection platform.Methods Using high-throughput,multi-sample and low-cost microfluidic technology,GSCs and neural stem cells(NSCs)were transfected with miR-874.A series of cell molecular biological experiments,such as qPCR detection of intracellular miR-874 expression,were carried out to study the effect of miR-874 on the growth and apoptosis of glioblastoma stem cells.Results The expression of miR-874 in GSCs was significantly decreased,about 2%-40%of the expression in NSCs.By transfection of miR-874 in GSCs with dendrimer,the number of GSCs decreased significantly and the numb indicating a killing effect of the GSCs by the miR-874.Conclusion The expression of miR-874 decreased significantly in GSCs.Overexpression of miR-874 in GSCs leads to significant cell growth inhibition and death,which is helpful for the development of novel brain cancer drugs and therapies based on miRNA.
作者 李彦钊 张绪新 孙晶 郎明非 任刚 邓东风 Li Yanzhao;Zhang Xuxin;Sun Jing;Lang Mingfei;Ren Gang;Deng Dongfeng(Department of Neurosurgery,Affiliated Zhongshan Hospital of Dalian University,Dalian 116001,China)
出处 《中华脑科疾病与康复杂志(电子版)》 2020年第4期205-208,共4页 Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition)
关键词 胶质母细胞瘤干细胞 神经干细胞 微流控平台 miRNA-874 Glioblastoma stem cell Neural stem cell Microfluidic platform miRNA-874
  • 相关文献

参考文献1

二级参考文献12

  • 1Wen PY, Kesari S. Malignant gliomas in adults [ J ]. N Engl J Med, 2008,359 ( 17 ) :492 -507.
  • 2Aoki T, Hashimoto N, Matsutani M. Management of glioblastoma [ J ]. Expert Opin Pharmacother,2007,8(18) :3133-3146.
  • 3Muniategui A, Nogales-Cadenas R, Vazquez M, et al. Quantification of miRNA-mRNA interactions [ J ]. PLoS one,2012,7 (2) : e30766.
  • 4Calin GA, Croce CM. MicroRNA signatures in human cancers [ J ]. Nat Rev Cancer,2006,6( 11 ) :857-866.
  • 5Calin GA, Scvignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers [ J ]. Proc Nat1 Acad Sci U S A ,2004,101 (9) :2999-3004.
  • 6Garzon R, Fabbri M, Cimmino A, et al. MiemRNA expression and function in cancer[ J]. Trends Mol Med ,2006,12(12) :580-587.
  • 7Cowland JB, Hother C, Grcnbaek K. MieroRNAs and cancer [ J ]. AP- MIS ,2007,115 (10) : 1090-1010.
  • 8Wuchty S, Arjona D, Li A. Prediction of associations between microR- NAs and gene expression in glioma biology [ J ]. PLoS One, 2011,6 (2) :e1468.
  • 9Lui WO, Pourmand N, Patterson BK, et al. Patterns of known and no- vel small RNAs in human cervical cancer [ J ]. Cancer Res, 2007,67 ( 13 ) :6031-6043.
  • 10Nohata N, Hanazawa T, Kikkawa N, et al. Turnout suppressive mi- croRNA-874 regulates novel cancer net-works in maxillary sinus squa- mous cell carcinoma [ J ]. Br J Cancer,2011,105 (6) :833-841.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部